Literature DB >> 25585378

Sodium tanshinone IIA sulfonate for reduction of periprocedural myocardial injury during percutaneous coronary intervention (STAMP trial): rationale and design.

Shuai Mao1, Lei Wang2, Xujie Zhao2, Hongcai Shang3, Minzhou Zhang4, Aleksander Hinek5.   

Abstract

Entities:  

Keywords:  Non-ST-segment elevation acute coronary syndrome; Percutaneous coronary intervention; Periprocedural myocardial infarction; Sodium tanshinone IIA sulfonate

Mesh：

Substances：

Year:  2015        PMID： 25585378     DOI： 10.1016/j.ijcard.2014.12.166

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  8 in total

1.  Shenzhu Guanxin Recipe Granules () for Improving Exercise Tolerance in Patients with Stable Angina (SERIES Trial): A Protocol of Multicenter, Randomized, Double-Blind, Placebo Parallel Controlled Clinical Trial.

Authors:  Shuai Mao; Dan-Ping Xu; Xiao-Jing Dang; Winny Li; Huan-Lin Wu
Journal:  Chin J Integr Med       Date:  2018-10-17       Impact factor: 1.978

Review 2.  Salvia miltiorrhizaBurge (Danshen): a golden herbal medicine in cardiovascular therapeutics.

Authors:  Zhuo-Ming Li; Suo-Wen Xu; Pei-Qing Liu
Journal:  Acta Pharmacol Sin       Date:  2018-04-26       Impact factor: 6.150

3.  Rescue therapy with Tanshinone IIA hinders transition of acute kidney injury to chronic kidney disease via targeting GSK3β.

Authors:  Chunming Jiang; Wei Zhu; Xiang Yan; Qiuyuan Shao; Biao Xu; Miao Zhang; Rujun Gong
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

4.  Efficacy of Danlou Tablet in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized Trial.

Authors:  Lei Wang; Xujie Zhao; Shuai Mao; Shaonan Liu; Xinfeng Guo; Liheng Guo; Tinghai Du; Haiyu Yang; Fuhai Zhao; Keng Wu; Hongliang Cong; Yang Wu; Phillip C Yang; Keji Chen; Minzhou Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2016-11-08       Impact factor: 2.629

5.  Simultaneous Determination of Eight Phenolic Acids, Five Saponins and Four Tanshinones for Quality Control of Compound Preparations Containing Danshen-Sanqi Herb-pair by HPLC-DAD.

Authors:  Hong Yao; Xiaomei Huang; Shaoguang Li; Youjia Wu; Xinhua Lin; Peiying Shi
Journal:  Pharmacogn Mag       Date:  2017 Jan-Mar       Impact factor: 1.085

6.  AFC1 Compound Attenuated MI/R-Induced Ventricular Remodeling via Inhibiting PDGFR and STAT Pathway.

Authors:  Jie Liu; Xiaohui Zhou; Qingshu Meng; Kevin W Huang; Jing Liu; Jinjun Tie; Rulin Zhuang; Guohan Chen; Yuhui Zhang; Lu Wei; Li Huang; Chun Guang Li; Binghui Wang; Huimin Fan; Zhongmin Liu
Journal:  Front Pharmacol       Date:  2019-10-15       Impact factor: 5.810

7.  Kinetics of cytochrome P450 enzymes for metabolism of sodium tanshinone IIA sulfonate in vitro.

Authors:  Dong-Sheng Ouyang; Wei-Hua Huang; Dan Chen; Wei Zhang; Zhi-Rong Tan; Jing-Bo Peng; Yi-Cheng Wang; Ying Guo; Dong-Li Hu; Jian Xiao; Yao Chen
Journal:  Chin Med       Date:  2016-03-22       Impact factor: 5.455

8.  Tanshinone IIA promotes the proliferation of WB-F344 hepatic oval cells via Wnt/β-catenin signaling.

Authors:  Xingyu Ze; Jidong Jia; Xinmin Li; Hong You; Xinyan Zhao; Dong Zhang; Baoen Wang
Journal:  Mol Med Rep       Date:  2015-12-18       Impact factor: 2.952
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.